Fill out this form to email this article to a friend
Yet another biotech firm headed here
An Oregon-based researcher plans a Port St. Lucie site.
Associated Press
Published January 9, 2008
PORT ST. LUCIE - An Oregon-based research institute plans to open a 130,000-square-foot campus on Florida's east coast, adding to the growing biotech cluster forming in the region, officials announced Tuesday. The Oregon Health & Science University's Vaccine and Gene Therapy Institute said it will create 200 jobs in the area over the next 10 years, enticed by $117.8-million in state and local incentives. The institute, based in Beaverton, Ore., plans to build its facility next to the Torrey Pines Institute for Molecular Studies, based in La Jolla, Calif., which announced last year it had chosen Port St. Lucie for its 100,000-square-foot research center. The move "further develops Florida as a biotech hub and establishes the Sunshine State as a global leader in medical research and development," Gov. Charlie Crist said in a statement. The institute was established in 2001 to study vaccine development and gene therapy approaches to treating diseases.
[Last modified January 9, 2008, 00:17:59]
Share your thoughts on this story
|